Tokyo Tape
Sign in
← Oncolys BioPharma

Half-year report · Q2

4588.TEDINET S100U7CS
Period2024-01-01 → 2024-06-30
Filed2024-08-09
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 45
MetricValuePeriodScopeSource row
Revenue¥31m2024-01-01 → 2024-06-30StandaloneNet sales
Revenue¥63m2023-01-01 → 2023-12-31StandaloneNet sales (5-year summary)
Revenue¥63m2023-01-01 → 2023-06-30StandaloneNet sales
Operating income−¥793m2024-01-01 → 2024-06-30StandaloneOperating income
Operating income−¥901m2023-01-01 → 2023-06-30StandaloneOperating income
Ordinary income−¥753m2024-01-01 → 2024-06-30StandaloneOrdinary income
Ordinary income−¥1.9bn2023-01-01 → 2023-12-31StandaloneOrdinary income loss (5-year summary)
Ordinary income−¥867m2023-01-01 → 2023-06-30StandaloneOrdinary income
Profit before tax−¥753m2024-01-01 → 2024-06-30StandaloneIncome before income taxes
Profit before tax−¥867m2023-01-01 → 2023-06-30StandaloneIncome before income taxes
Net income−¥755m2024-01-01 → 2024-06-30StandaloneProfit loss
Net income−¥1.9bn2023-01-01 → 2023-12-31StandaloneNet income loss (5-year summary)
Net income−¥869m2023-01-01 → 2023-06-30StandaloneProfit loss
Total assets¥1.9bnat 2024-06-30StandaloneAssets
Total assets¥2.0bnat 2023-12-31StandaloneAssets
Total assets¥1.9bnat 2023-06-30StandaloneTotal assets (5-year summary)
Total liabilities¥469mat 2024-06-30StandaloneLiabilities
Total liabilities¥567mat 2023-12-31StandaloneLiabilities
Net assets / equity¥1.4bnat 2024-06-30StandaloneNet assets
Net assets / equity¥1.5bnat 2023-12-31StandaloneNet assets
Net assets / equity¥1.3bnat 2023-06-30StandaloneNet assets (5-year summary)
Cash and deposits¥1.1bnat 2024-06-30StandaloneCash and deposits
Cash and deposits¥1.5bnat 2023-12-31StandaloneCash and deposits
Cash & equivalents¥872mat 2024-06-30StandaloneCash and cash equivalents
Cash & equivalents¥1.3bnat 2023-12-31StandaloneCash and cash equivalents
Cash & equivalents¥1.1bnat 2023-06-30StandaloneCash and cash equivalents
Cash & equivalents¥1.5bnat 2022-12-31dStandaloneCash and cash equivalents
Operating cash flow−¥1.1bn2024-01-01 → 2024-06-30StandaloneNet cash provided by used in operating activities
Operating cash flow−¥1.3bn2023-01-01 → 2023-12-31StandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥452m2023-01-01 → 2023-06-30StandaloneNet cash provided by used in operating activities
Investing cash flow−¥1m2024-01-01 → 2024-06-30StandaloneNet cash provided by used in investment activities
Investing cash flow−¥5m2023-01-01 → 2023-12-31StandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥748,0002023-01-01 → 2023-06-30StandaloneNet cash provided by used in investment activities
Financing cash flow¥686m2024-01-01 → 2024-06-30StandaloneNet cash provided by used in financing activities
Financing cash flow¥1.1bn2023-01-01 → 2023-12-31StandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥45m2023-01-01 → 2023-06-30StandaloneNet cash provided by used in financing activities
EPS (basic)¥-36.962024-01-01 → 2024-06-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-108.922023-01-01 → 2023-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-50.162023-01-01 → 2023-06-30StandaloneBasic earnings loss per share (5-year summary)
Equity ratio74.7%at 2024-06-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio71.5%at 2023-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio68.7%at 2023-06-30StandaloneEquity to asset ratio (5-year summary)
Shares issued20,961,600at 2024-06-30StandaloneTotal number of issued shares (5-year summary)
Shares issued19,717,100at 2023-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued17,405,200at 2023-06-30StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 438
ItemContextValueUnit
Cost of salesCurrentYTDDuration_NonConsolidatedMember－JPY
Gross profitPrior1YTDDuration_NonConsolidatedMember30604000JPY
Gross profitCurrentYTDDuration_NonConsolidatedMember31384000JPY
Selling general and administrative expensesPrior1YTDDuration_NonConsolidatedMember931594000JPY
Selling general and administrative expensesCurrentYTDDuration_NonConsolidatedMember824755000JPY
Operating incomePrior1YTDDuration_NonConsolidatedMember-900989000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember-793371000JPY
Interest income noiPrior1YTDDuration_NonConsolidatedMember533000JPY
Interest income noiCurrentYTDDuration_NonConsolidatedMember1047000JPY
Dividends income noiPrior1YTDDuration_NonConsolidatedMember3000JPY
Dividends income noiCurrentYTDDuration_NonConsolidatedMember5000JPY
Foreign exchange gains noiPrior1YTDDuration_NonConsolidatedMember35051000JPY
Foreign exchange gains noiCurrentYTDDuration_NonConsolidatedMember48518000JPY
Other noiPrior1YTDDuration_NonConsolidatedMember177000JPY
Other noiCurrentYTDDuration_NonConsolidatedMember22000JPY
Non operating incomePrior1YTDDuration_NonConsolidatedMember35765000JPY
Non operating incomeCurrentYTDDuration_NonConsolidatedMember49593000JPY
Interest expenses noePrior1YTDDuration_NonConsolidatedMember1781000JPY
Interest expenses noeCurrentYTDDuration_NonConsolidatedMember2185000JPY
Amortization of restricted stock remuneration noePrior1YTDDuration_NonConsolidatedMember435000JPY
Amortization of restricted stock remuneration noeCurrentYTDDuration_NonConsolidatedMember2183000JPY
Share acquisition rights issuance costs noePrior1YTDDuration_NonConsolidatedMember－JPY
Share acquisition rights issuance costs noeCurrentYTDDuration_NonConsolidatedMember2310000JPY
Stock issuance cost noePrior1YTDDuration_NonConsolidatedMember－JPY
Stock issuance cost noeCurrentYTDDuration_NonConsolidatedMember2466000JPY
Other noePrior1YTDDuration_NonConsolidatedMember－JPY
Other noeCurrentYTDDuration_NonConsolidatedMember73000JPY
Non operating expensesPrior1YTDDuration_NonConsolidatedMember2217000JPY
Non operating expensesCurrentYTDDuration_NonConsolidatedMember9219000JPY
Ordinary incomePrior1YTDDuration_NonConsolidatedMember-867441000JPY
Ordinary incomeCurrentYTDDuration_NonConsolidatedMember-752997000JPY
Gain on sales of noncurrent assets eiPrior1YTDDuration_NonConsolidatedMember136000JPY
Gain on sales of noncurrent assets eiCurrentYTDDuration_NonConsolidatedMember－JPY
Extraordinary incomePrior1YTDDuration_NonConsolidatedMember136000JPY
Extraordinary incomeCurrentYTDDuration_NonConsolidatedMember－JPY
Income before income taxesPrior1YTDDuration_NonConsolidatedMember-867305000JPY
Income before income taxesCurrentYTDDuration_NonConsolidatedMember-752997000JPY
Income taxes currentPrior1YTDDuration_NonConsolidatedMember1457000JPY
Income taxes currentCurrentYTDDuration_NonConsolidatedMember1871000JPY
Income taxesPrior1YTDDuration_NonConsolidatedMember1457000JPY
Income taxesCurrentYTDDuration_NonConsolidatedMember1871000JPY
Profit lossPrior1YTDDuration_NonConsolidatedMember-868762000JPY
Profit lossCurrentYTDDuration_NonConsolidatedMember-754868000JPY
Income before income taxesPrior1YTDDuration_NonConsolidatedMember-867305000JPY
Income before income taxesCurrentYTDDuration_NonConsolidatedMember-752997000JPY
Depreciation and amortization ope cfPrior1YTDDuration_NonConsolidatedMember141000JPY
Depreciation and amortization ope cfCurrentYTDDuration_NonConsolidatedMember－JPY
Amortization of restricted stock remuneration ope cfPrior1YTDDuration_NonConsolidatedMember435000JPY
Amortization of restricted stock remuneration ope cfCurrentYTDDuration_NonConsolidatedMember2183000JPY
Share based compensation expenses ope cfPrior1YTDDuration_NonConsolidatedMember5488000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identitynon_consolidated 2023-12-31pass rounding
balance sheet identitynon_consolidated 2024-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2023-12-31pass
statement vs summary · net assetsnon_consolidated 2024-06-30pass
statement vs summary · operating cash flownon_consolidated 2023-01-01/2023-06-30pass
statement vs summary · operating cash flownon_consolidated 2024-01-01/2024-06-30pass
statement vs summary · revenuenon_consolidated 2023-01-01/2023-06-30pass
statement vs summary · revenuenon_consolidated 2024-01-01/2024-06-30pass
statement vs summary · total assetsnon_consolidated 2023-12-31pass
statement vs summary · total assetsnon_consolidated 2024-06-30pass